We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$6.12B
AUM Growth
+$1.19B
Cap. Flow
+$827M
Cap. Flow %
13.51%
Top 10 Hldgs %
13.15%
Holding
801
New
237
Increased
195
Reduced
118
Closed
223

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$70M
2
BABA icon
Alibaba
BABA
+$55M
3
MO icon
Altria Group
MO
+$54.7M
4
BAC icon
Bank of America
BAC
+$40.3M
5
C icon
Citigroup
C
+$40M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$111M
2
BPL
Buckeye Partners, L.P.
BPL
+$75.6M
3
VICI icon
VICI Properties
VICI
+$54.6M
4
DRE
Duke Realty Corp.
DRE
+$40.6M
5
HR icon
Healthcare Realty
HR
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 13.69%
2 Real Estate 12.33%
3 Industrials 8.42%
4 Healthcare 6.58%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STML
551
DELISTED
Stemline Therapeutics, Inc.
STML
$372K 0.01%
35,000
+15,000
+75% +$149K
KALV
552
DELISTED
KalVista Pharmaceuticals
KALV
$356K 0.01%
20,000
-34,000
-63% -$444K
EXEL icon
553
CALL
Exelixis
EXEL
$14.1B
$352K 0.01%
+20,000
New +$339K
MRUS
554
DELISTED
Merus
MRUS
$352K 0.01%
25,000
-5,000
-17% -$80.4K
LAB icon
555
Standard BioTools
LAB
$305M
$348K 0.01%
100,000
– –
PEN icon
556
Penumbra
PEN
$12.6B
$347K 0.01%
2,115
+115
+6% +$18.3K
NTRA icon
557
Natera
NTRA
$37B
$337K 0.01%
+10,000
New +$369K
VNDA icon
558
Vanda Pharmaceuticals
VNDA
$316M
$328K 0.01%
20,000
-30,000
-60% -$454K
ENBL
559
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$326K 0.01%
+32,500
New +$331K
GME icon
560
PUT
GameStop
GME
$9.62B
$303K 0.01%
199,600
– –
VRAY
561
DELISTED
ViewRay, Inc.
VRAY
$295K ﹤0.01%
70,000
-15,000
-18% -$48.5K
KPTI icon
562
Karyopharm Therapeutics
KPTI
$162M
$288K ﹤0.01%
1,000
-667
-40% -$145K
BLUE
563
DELISTED
bluebird bio
BLUE
$278K ﹤0.01%
245
-25
-9% -$27.2K
DVAX
564
DELISTED
Dynavax Technologies
DVAX
$275K ﹤0.01%
48,000
+3,000
+7% +$16K
PGNX
565
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$270K ﹤0.01%
53,000
+3,000
+6% +$15.9K
TEN
566
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$262K ﹤0.01%
+20,000
New +$262K
EAF icon
567
GrafTech
EAF
$204M
$261K ﹤0.01%
+2,250
New +$283K
AERI
568
DELISTED
Aerie Pharmaceuticals
AERI
$254K ﹤0.01%
10,500
-9,500
-48% -$197K
SGMO
569
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$251K ﹤0.01%
30,000
– –
VYGR icon
570
Voyager Therapeutics
VYGR
$186M
$223K ﹤0.01%
16,000
+6,000
+60% +$87.2K
SWAV
571
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$220K ﹤0.01%
+5,000
New +$185K
FATE icon
572
Fate Therapeutics
FATE
$283M
$196K ﹤0.01%
10,000
-10,000
-50% -$159K
FENC icon
573
Fennec Pharmaceuticals
FENC
$357M
$172K ﹤0.01%
26,500
+1,500
+6% +$8.06K
BRQS
574
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$168K ﹤0.01%
486
– –
TVRD
575
Tvardi Therapeutics
TVRD
$23.7M
$161K ﹤0.01%
+278
New +$195K
21 22
23
24 25

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Weiss Multi-Strategy Advisers held 801 positions worth $6.12B, up 24% from $4.93B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Weiss Multi-Strategy Advisers deployed $827M of net new capital in Q4 2019, opening 237 new positions and adding to 195 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 443,110 shares worth $73.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 10% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was VICI Properties, an estimated $54.6M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q4 2019 buy was iShares Russell 2000 ETF: 443,110 shares worth $73.4M.
  • Weiss Multi-Strategy Advisers added most to Citigroup in Q4 2019, an estimated $40M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2019 reduction was VICI Properties, cutting an estimated $54.6M.
  • Weiss Multi-Strategy Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $111M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 13% of its $6.12B portfolio in Q4 2019.
  • Weiss Multi-Strategy Advisers opened 237 new positions and closed 223 in Q4 2019.
  • Weiss Multi-Strategy Advisers's portfolio value rose 24% quarter-over-quarter to $6.12B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.